O
James Hiddleston, a company director here, told BioInform that Oxford Molecular’s bioinformatics business has been expanding and that a new strategy calls for concentrating resources on development of drug discovery software.
O
James Hiddleston, a company director here, told BioInform that Oxford Molecular’s bioinformatics business has been expanding and that a new strategy calls for concentrating resources on development of drug discovery software.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.